Stocks
Allogene Therapeutics (ALLO) P/E US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -11.1 | 0.00 | 0.00 | -1.61 | -1.58 | -2.77 | ||
| Changes by years, y/y, % | -8% | -100% | -2% | -33.5% | |||||
Allogene Therapeutics. P/E
Allogene Therapeutics. P/E, changes, %
Allogene Therapeutics (ALLO) P/E US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/E | ? | -1.25 | -1.04 | -1.30 | -1.58 | -3.37 | -2.77 | |
| Changes by years, y/y, % | -36% | -9% | +171% | |||||
| Changes by quarters, q/q, % | -28% | -16% | +24% | +22% | +113% | |||
